loading

Avalo Therapeutics Inc Stock (AVTX) Forecast

The Avalo Therapeutics Inc (AVTX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $3.0019, representing a -69.86% decrease from the current price of $9.96. The highest analyst price target is $3.0203, and the lowest is $2.9835.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month AVTX Price Target
Average 5.2732 (-47.06% Downside)
loading

Is Avalo Therapeutics Inc (AVTX) A Buy Now?

Oscillators
Name Value Action
RSI(14) 35.38 Neutral
STOCH(9,6) 26.12 Neutral
STOCHRSI(14) 26.48 Neutral
MACD(12,26) -0.0428 Sell
ADX(14) 30.60 Sell
William %R -93.12 Buy
CCI(14) -173.64 Sell
Buy: 1 Sell: 3 Neutral: 3
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
12.22
Sell
11.78
Sell
MA20
12.81
Sell
12.05
Sell
MA50
11.07
Sell
11.48
Sell
MA100
10.76
Sell
10.93
Sell
MA200
10.50
Sell
9.2657
Buy
Buy: 1 Sell: 9 Neutral: 0
Summary: Sell
According to our latest analysis, AVTX could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 12 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on AVTX, as trading bearish markets can be challenging and may result in losses.
  1. RSI (Relative Strength Index): The RSI(14) value of 35.38 indicates that AVTX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 26.12 indicates that AVTX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 26.48 indicates that AVTX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 30.6 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -173.64 indicates that AVTX is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.

Long-term AVTX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Avalo Therapeutics Inc financial reports and earnings history, Avalo Therapeutics Inc (AVTX) stock could reach $10.77 by 2030, $62.12 by 2040 and $85.19 by 2050. See the projected annual prices until 2050 of the Avalo Therapeutics Inc stock below:

  • Avalo Therapeutics Inc (AVTX) is expected to reach an average price of $36.39 in 2035, with a high prediction of $36.09 and a low estimate of $36.41. This indicates an $265.38% rise from the last recorded price of $9.96.
  • Avalo Therapeutics Inc (AVTX) stock is projected to chart a bullish course in 2040, with an average price target of $63.03, representing an $532.82% surge from its current level. The forecast ranges from a conservative $61.70 to a sky-high $62.12.
  • Our analysts predict Avalo Therapeutics Inc (AVTX) to jump 404.20% by 2045, soaring from $47.78 to an average price of $50.22, potentially reaching $49.82. While $47.78 is the low estimate, the potential upside is significant.
  • Avalo Therapeutics Inc (AVTX) stock is expected to climb by 2050, reaching an average of $85.30, a $756.47% jump from its current level. However, a wide range of estimates exists, with high and low targets of $85.19 and $85.32, respectively, highlighting the market's uncertainty.

Avalo Therapeutics Inc Stock (AVTX) Year by Year Forecast

Avalo Therapeutics Inc Stock (AVTX) Price Forecast for 2024

Our forecast for AVTX stock price in 2024 now indicates an average price target of $17.50 with a high forecast of $34.46 and a low forecast of $0.535. The average prediction reflects an increase of +75.68% from the last recorded price of $9.96.
Month Average Low High Change from today's price
December, 2024 $3.878 $2.9835 $3.0203 -61.06%

Avalo Therapeutics Inc Stock (AVTX) Price Forecast for 2025

Avalo Therapeutics Inc Stock (AVTX) is expected to reach an average price of $6.0099 in 2025, with a high prediction of $7.563 and a low estimate of $4.4568. This indicates an -39.66% fall from the last recorded price of $9.96.
Month Average Low High Change from today's price
January, 2025 $8.5242 $4.584 $7.563 -14.42%
February, 2025 $6.9059 $7.7747 $7.3298 -30.66%
March, 2025 $5.2288 $5.8852 $5.0624 -47.50%
April, 2025 $7.445 $5.1921 $6.535 -25.25%
May, 2025 $6.118 $6.1947 $6.6283 -38.57%
June, 2025 $6.6209 $6.1244 $5.9244 -33.53%
July, 2025 $5.2771 $5.2871 $7.0584 -47.02%
August, 2025 $4.62 $4.4568 $4.3236 -53.61%
September, 2025 $4.573 $4.998 $4.7824 -54.09%
October, 2025 $5.1291 $4.9994 $4.8491 -48.50%
November, 2025 $5.9971 $5.1156 $5.8521 -39.79%
December, 2025 $7.2383 $6.4753 $6.8083 -27.33%

Avalo Therapeutics Inc Stock (AVTX) Price Forecast for 2026

The predicted value for Avalo Therapeutics Inc (AVTX) in 2026 is set at an average of $4.4665. Estimates vary from a peak of $8.6729 to a trough of $0.26, indicating an -55.16% surge from the present price of $9.96.
Month Average Low High Change from today's price
January, 2026 $7.8012 $7.2915 $7.4012 -21.67%
February, 2026 $6.5591 $6.8641 $7.6477 -34.15%
March, 2026 $5.9171 $6.6074 $6.6439 -40.59%
April, 2026 $5.2133 $6.2288 $6.3068 -47.66%
May, 2026 $8.6541 $5.2464 $8.625 -13.11%
June, 2026 $8.6642 $8.6515 $8.6729 -13.01%
July, 2026 $8.5639 $8.5693 $8.6237 -14.02%
August, 2026 $8.3876 $8.3883 $8.5146 -15.79%
September, 2026 $8.215 $8.234 $8.3119 -17.52%
October, 2026 $8.0894 $8.0919 $8.1788 -18.78%
November, 2026 $7.9703 $7.997 $8.0461 -19.98%
December, 2026 $3.6365 $0.26 $7.9335 -63.49%

Avalo Therapeutics Inc Stock (AVTX) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Avalo Therapeutics Inc (AVTX) is $13.58, with a high forecast of $27.05 and a low forecast of $0.0982. This indicates an +36.31% increase from the last price of $9.96.
Month Average Low High Change from today's price
January, 2027 $3.0195 $3.3629 $2.9795 -69.68%
February, 2027 $3.1324 $3.2127 $3.1375 -68.55%
March, 2027 $9.0314 $2.8053 $27.05 -9.32%
April, 2027 $9.8985 $3.7682 $11.49 -0.62%
May, 2027 $1.3071 $0.2529 $9.9152 -86.88%
June, 2027 $3.1147 $0.1059 $4.0747 -68.73%
July, 2027 $1.0312 $0.0982 $3.4282 -89.65%
August, 2027 $2.4171 $3.7981 $2.4906 -75.73%
September, 2027 $13.30 $5.4635 $12.56 +33.49%
October, 2027 $14.17 $13.62 $12.80 +42.25%
November, 2027 $15.62 $15.36 $14.80 +56.85%
December, 2027 $15.58 $14.73 $14.80 +56.47%

Avalo Therapeutics Inc Stock (AVTX) Price Forecast for 2028

In 2028, Avalo Therapeutics Inc (AVTX) is projected to reach an average price of $17.00, with a high projection of $19.09 and a low estimate of $14.91. This indicates an +70.68% rise from the last price of $9.96.
Month Average Low High Change from today's price
January, 2028 $19.15 $16.25 $17.84 +92.27%
February, 2028 $18.50 $19.23 $19.09 +85.78%
March, 2028 $16.46 $17.11 $17.28 +65.24%
April, 2028 $17.64 $16.38 $17.40 +77.14%
May, 2028 $17.02 $17.13 $17.64 +70.84%
June, 2028 $17.37 $16.95 $16.78 +74.42%
July, 2028 $15.91 $17.11 $17.74 +59.72%
August, 2028 $15.04 $14.91 $15.60 +51.00%
September, 2028 $14.85 $15.27 $15.11 +49.06%
October, 2028 $15.21 $15.20 $14.97 +52.73%
November, 2028 $15.94 $15.13 $15.79 +60.03%
December, 2028 $16.72 $16.38 $16.36 +67.87%

Avalo Therapeutics Inc Stock (AVTX) Price Forecast for 2029

The 2029 price forecast for Avalo Therapeutics Inc Stock (AVTX) is $12.91 on average, with a high prediction of $17.65 and a low estimate of $8.1801. This represents an +29.66% increase from the previous price of $9.96.
Month Average Low High Change from today's price
January, 2029 $17.41 $17.01 $17.01 +74.82%
February, 2029 $16.02 $16.33 $17.22 +60.88%
March, 2029 $15.23 $16.03 $16.00 +52.95%
April, 2029 $14.32 $15.48 $15.51 +43.78%
May, 2029 $17.64 $14.34 $17.65 +77.11%
June, 2029 $17.50 $17.50 $17.55 +75.74%
July, 2029 $17.28 $17.29 $17.43 +73.54%
August, 2029 $16.90 $16.90 $17.21 +69.64%
September, 2029 $16.62 $16.63 $16.78 +66.89%
October, 2029 $16.27 $16.27 $16.53 +63.32%
November, 2029 $16.00 $16.03 $16.19 +60.65%
December, 2029 $10.05 $8.1801 $15.93 +0.87%

Avalo Therapeutics Inc Stock (AVTX) Price Forecast for 2030

Avalo Therapeutics Inc Stock (AVTX) is expected to reach an average price of $13.51 in 2030, with a high forecast of $26.69 and a low forecast of $0.3305. This signifies an +35.63% surge from the last price of $9.96.
Month Average Low High Change from today's price
January, 2030 $10.72 $11.10 $10.77 +7.62%
February, 2030 $10.68 $10.80 $10.76 +7.28%
March, 2030 $6.9393 $10.21 $19.65 -30.33%
April, 2030 $1.4234 $0.4872 $7.7328 -85.71%
May, 2030 $11.54 $0.3305 $10.70 +15.86%
June, 2030 $9.7782 $12.88 $11.21 -1.82%
July, 2030 $13.55 $10.87 $12.05 +36.01%
August, 2030 $14.79 $16.28 $14.90 +48.45%
September, 2030 $26.12 $17.80 $24.78 +162.25%
October, 2030 $26.21 $25.76 $24.83 +163.11%
November, 2030 $27.51 $27.36 $26.69 +176.23%
December, 2030 $24.78 $26.47 $26.60 +148.76%
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Cap:     |  Volume (24h):